Pneumovax 23

BIOLOGICAL11 trials

Conditions

DiabetesHealthy ControlsHealthy VolunteersInflammatory ResponseLymphomaObesityPneumococcal DiseasePneumococcal Infections

Early Phase 1

Persistent Readiness Through Early Prediction Immunization Study

CompletedNCT05346302

Texas A&M UniversityInflammatory Response

Start: 2022-02-08End: 2022-12-21Updated: 2023-02-14

Phase 1

Pneumococcal Adult-dose Ranging Immunization Study

CompletedNCT00169234

Kaiser PermanentePneumonia

Start: 2003-05-31End: 2005-02-28Updated: 2017-10-13

Pneumococcal Reference Standard

CompletedNCT00479323

National Institute of Allergy and Infectious Diseases (NIAID)Pneumococcal Infections

Start: 2007-06-30End: 2008-08-31Updated: 2016-12-26

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23

CompletedNCT02097589

University of FloridaHealthy Controls

Start: 2014-06-30End: 2014-09-30Updated: 2015-09-28

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants

CompletedNCT02308540

PATHPneumococcal Disease

Start: 2015-01-12End: 2016-11-03Updated: 2019-08-02

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

CompletedNCT05163834

argenxHealthy Volunteers

Start: 2021-11-17End: 2022-03-08Updated: 2022-03-17

Phase 2

Pneumococcal Vaccination of Fiji Infants

CompletedNCT00170612

University of MelbournePneumococcal Infections

Start: 2005-11-30End: 2008-08-31Updated: 2008-10-21

Phase 3

Long-term outcomes in immunologically low-risk kidney transplant recipients using tacrolimus

Not yet recruitingCTIS2024-513394-42-01

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Vaccination response

Target: 66Updated: 2025-01-27

Phase 4

Vaccine Responses in Patients With B Cell Malignancies

RecruitingNCT05170399

National Heart, Lung, and Blood Institute (NHLBI)Lymphoma

Start: 2022-09-14End: 2036-11-15Target: 350Updated: 2026-08-04

Do GLP-1 based therapies improve the immunological response to vaccination in diabetes?

Not yet recruitingCTIS2026-525909-13-00

Radboud universitair medisch centrum StichtingDiabetes

Target: 100Updated: 2026-07-22

Unknown Phase

Effect of Obesity on Immune Response to Pneumovax 23

CompletedNCT02471014

University of FloridaObesity

Start: 2016-12-31End: 2019-05-16Updated: 2020-12-01

Frontiers in Immunology2026-05-07

Volatile organic compound and proteomics data from the same exhaled breath condensate sample

Journal of Breath Research2025-07-231 citations

A randomized, triple-blinded, placebo-controlled clinical trial evaluating immune responses of Typhim Vi and PPSV23 vaccines in healthy adults: The PREP study

Vaccine2024-09-073 citations

The Age of Cyclic Dinucleotide Vaccine Adjuvants.

2020-08-1374 citations

Obesity and STING1 genotype associate with 23-valent pneumococcal vaccination efficacy

JCI Insight2020-05-0621 citations

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial

Vaccine2019-12-1430 citations

Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial

Vaccine2019-01-268 citations